Advertisement

Pharmacy World and Science

, Volume 26, Issue 5, pp 289–296 | Cite as

Computer-assisted medication review for asthmatic patients as a basis for intervention Constructing and validating an algorithmic computer instrument in pharmacy practice

  • Ada G.G. Stuurman-Bieze
  • Paul B. van den Berg
  • Th. (Dick) F.J. Tromp
  • Lolkje T.W. de Jong-van den Berg
Article

Abstract

Objective: To construct and validate a computer instrument that identifies asthma patients receiving – theoretically – suboptimal drug therapy in community pharmacies, by the use of patient medication records. This selection enables the pharmacist to assist these patients in using medicines appropriately.

Methods: According to Dutch asthma guidelines which describe a stepwise approach and in order to define correct profiles for the use at each level of these guidelines, the optimum use of drugs in the different levels in asthma treatment was expressed in defined daily doses (DDDs) per pharmacological drug-group during a period of one year. An algorithmic computer instrument was developed to select patients with medication use deviant from these profiles. By using nine different selection profiles, the computer instrument stratified patients according to the medication records filed in the pharmacy computer. Patient medication records in four community pharmacies were investigated to validate the selection profiles as indicators for theoretically suboptimal drug use by asthma patients. The validation was performed by comparing the professional judgement of participating pharmacists with the selections made by the computer.

Main outcome measure: Positive predictive value and negative predictive value of the selection made by algorithmic computer instrument. Rate of false-positive results.

Results: The computer instrument identified asthma patients using theoretically suboptimal drug therapy with approximately 95% predictive value compared with the professional judgement of the pharmacists. The rate of false-positive results was 5%.

Conclusion: The results of the algorithmic computer instrument and the professional judgement of the pharmacists are in close agreement. The instrument will be utilised in further research in the IPMP study (Interventions on the principle of Pulmonary Medication Profiles) investigating the role of Dutch community pharmacists in counselling patients who are at risk of suboptimal drug use in the treatment of their asthma.

Asthma Computer algorithm Guidelines Identification Indicators Patient medication records Pharmacist The Netherlands Validation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Geijer RMM, Van Hensbergen W, Bottema BJAM, Van Schayck CP, Sachs APE, Smeele IJM et al. NHG-Standaard Astma bij vol-wassenen: behandeling. [NHG Asthma standard for adults: treatment.] Huisarts Wet 1997; 40: 443–54.Google Scholar
  2. 2.
    Geijer RMM, Van Hensbergen W, Bottema BJAM, Van Schayck CP, Sachs APE, Smeele IJM et al. NHG-Standaard Astma bij vol-wassenen: behandeling. [NHG Asthma standard for adults: treatment.] Huisarts Wet 2001; 44: 153–64.Google Scholar
  3. 3.
    Anonymus Global strategy for asthma management and pre-vention NHLBI/WHO report. Bethesda, Maryland: National In-stitutes of Health, 1995.Google Scholar
  4. 4.
    Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehto-nen K et al. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991; 325: 388–92.PubMedGoogle Scholar
  5. 5.
    Donahue JG, Weiss ST, Livingston JM, G oetsch MA, Greidener DK, Platt R. Inhaled steroids and the risk of hospitalisation for asthma. JAMA 1997; 277: 887–91.PubMedGoogle Scholar
  6. 6.
    Blais L, Ernst P, Boivin JF, Suissa S. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med 1998; 158: 126–32.PubMedGoogle Scholar
  7. 7.
    Lau HS, De Boer A, Beuning KS, Porsius A. Validation of phar-macy records in drug exposure assessment. J Clin Epidemiol 1997; 50: 619–25.CrossRefPubMedGoogle Scholar
  8. 8.
    Anonymus. Nederlandse Apotheek Norm. [Dutch Pharmacy Standard.] The Hague, The Netherlands: Royal Dutch Associa-tion for the Advancement of Pharmacy, 1996.Google Scholar
  9. 9.
    Van Mil JWF, Dudok van Heel MC, Boersma M, Tromp TFJ. Inter-ventions and documentation for drug-related problems in Dutch community pharmacies. Am J Health Syst Pharm 2001; 58: 1428–31.Google Scholar
  10. 10.
    Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical manage-mant of asthma in 1999: the Asthma Insights and Reality in Eu-rope (AIRE) study. Eur Respir J 2000; 16: 802–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533–43.PubMedGoogle Scholar
  12. 12.
    Schulz M, Verheyen F, Muehlig S, Mueller JM, Muehlbauer K, Knop-Schneickert E et al. Pharmaceutical care services for asthma patients: a controlled intervention study. J Clin Pharma-col 2001; 41: 668–76.CrossRefGoogle Scholar
  13. 13.
    Herborg H, Soendergaard B, Froekjaer B, Fonnesbaek L, Jor-gensen T, Hepler CD et al. Improving drug therapy for patients with asthma-part 1: patient outcomes. J Am Pharm Assoc 2001; 41: 539–50.Google Scholar
  14. 14.
    Naerhi U, Airaksinen M, Tanskanen P, Enlund H. The effects of a pharmacy-based intervention on the knowledge and attitudes of asthma patients. Patient Educ Couns 2001; 43: 171–7.CrossRefPubMedGoogle Scholar
  15. 15.
    De Smet PAGM, Koper JF, Kwint HF, Tinke JL. CARA CHECK-deel-nemers krijgen farmaco-epidemiologische ondersteuning. Helpende hand van WINAp en SFK. [Epidemiological support for CARA CHECK participants.] Pharm Weekbl 1998; 133; 1575–9.Google Scholar
  16. 16.
    Essink RTGM, Van den Hoff OP, Koper JF, De Smet PAGM. Wie wel, wie niet? CARA CHECK searches voor extra zorg. [Selecting asthma/COPD patients, searches for extra care.] Pharm Weekbl 2001; 136: 594–9.Google Scholar
  17. 17.
    Anonymus. Anatomical Therapeutic Chemical (ATC) Classifica-tion Index. WHO Collaborating Centre for Drug Statistics Meth-odology, 2001.Google Scholar
  18. 18.
    Tobi H, Van den Berg PB, De Jong-van den Berg LTW. The Inter-Action Database: synergy of science and practice in pharmacy. Lect Notes Comput Sci 2000; 1933: 206–11.Google Scholar
  19. 19.
    Lieu TA, Capra AM, Quesenberry CP, Mendoza GR, Mazar M. Computer based models to identify high-risk adults with asthma: is the glass half empty or half full? J Asthma 1999; 36: 359–70.PubMedGoogle Scholar
  20. 20.
    Mackinnon NJ, Hepler CD. Preventable drug-related morbidity in older adults (1. Indicator development). J Managed Care Pharm 2002; 8: 365–71.Google Scholar
  21. 21.
    Klein JJ, Van der Palen J, Seydel ER, Kerkhoff AHM. Medicijnken-nis van volwassenen met astma onvoldoende voor zelfbehande-ling. [Knowledge about medicines of adults with asthma insuf-ficient for self-treatment.] Ned Tijdschr Geneesk 1998; 142: 711–5.Google Scholar
  22. 22.
    Van der Palen J, Klein JJ, Kerkhoff AHM. Matige techniek bij het gebruik van inhalatiemedicatie door patiënten met chronische bronchitis of longemfyseem. [Poor inhalation technique of pa-tients with chronic bronchitis/pulmonary emphysema using in-halation medication.] Ned Tijdschr Geneesk 1994; 138: 1417–22.Google Scholar
  23. 23.
    Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care 1988; 26: 814–23.Google Scholar
  24. 24.
    Steiner JF, Prochazka AV. The assessment of refill compliance us-ing pharmacy records: methods, validity and applications. J Clin Epidemiol 1997; 50: 105–16.CrossRefPubMedGoogle Scholar
  25. 25.
    Van der Kuy A, Chief editor. Farmacotherapeutisch Kompas 1998. Amstelveen, The Netherlands: Centrale Medisch Pharma-ceutische Commissie van de Ziekenfondsraad, 1998.Google Scholar
  26. 26.
    Altman DG. Practical statistics for medical research. Boca Raton: Chapman and Hall/CRC, 1999.Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Ada G.G. Stuurman-Bieze
    • 1
    • 2
    • 3
  • Paul B. van den Berg
    • 2
  • Th. (Dick) F.J. Tromp
    • 3
  • Lolkje T.W. de Jong-van den Berg
    • 2
  1. 1.Apotheek WittesteijnWittesteijn 4EmmeloordThe Netherlands
  2. 2.Department of Social Pharmacy, Pharmacoepidemiology and PharmacotherapyGroningen University Institute for Drug Exploration (GUIDE)Groningen
  3. 3.Quality Institute for Pharmaceutical CareKampenThe Netherlands E-mail

Personalised recommendations